Kolexia
Magnani Alessandra Pédiatrie
Magnani Alessandra
Pédiatrie
Hôpital Necker Enfants Malades
Paris, France
63 Activités
271 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Drépanocytose Syndrome de Wiskott-Aldrich Thalassémie Bêta-Thalassémie Immunodéficience combinée grave Anémie Hémoglobinopathies Maladies d'immunodéficience primaire Maladie du greffon contre l'hôte

Collaborateurs

Voir plus
Cavazzana Marina
Cavazzana Marina
Hôpital Necker Enfants Malades, Paris, France
Magrin Elisa
Magrin Elisa
Hôpital Necker Enfants Malades, Paris, France
Moshous Despina
Moshous Despina
Hôpital Necker Enfants Malades, Paris, France
Blanche Stéphane
Blanche Stéphane
Hôpital Necker Enfants Malades, Paris, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Essai Clinique (Bluebird)   08 janvier 2024
ARTEGENE: A Phase 1/2 Open Label Non Randomized Study, Multicentric, Single Arm Evaluating the Safety and Efficacy of Gene Therapy of the Severe Combined Immunodeficiency (SCID) Caused by Mutations in the Human DCLRE1C Gene (Artemis) by Transplantation of a Single Dose of Autologous CD34+ Cells Transduced ex Vivo With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA
Essai Clinique (Assistance publique – Hôpitaux de Paris)   24 novembre 2023
Cryopreservation Impacts Allogenic Stem Cell Engraftment: Relation between Graft Quality Control and Post-Transplant Clinical Outcome
65th ASH Annual Meeting Abstracts   02 novembre 2023
Human Pro-T-Cell Manufacturing in Vitro Is a Safe Procedure for Hematopoietic Stem Cell Transplantation with Delayed T-Cell Reconstitution: Interim Results from 2 Different Clinical Trials
65th ASH Annual Meeting Abstracts   02 novembre 2023
Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Essai Clinique (Bluebird)   13 octobre 2023
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy.
Cell reports. Medicine   26 janvier 2023
Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patients.
The Journal of allergy and clinical immunology   10 janvier 2023
Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.
Nature medicine   15 octobre 2022
Method and impact of allografts cryopreservation during the Covid-19 pandemic: guidelines from the SFGM-TC.
Bulletin du cancer   02 juillet 2022
Correction to: Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy.
Bone marrow transplantation   11 mai 2022